Park Ha Biological prices $2 million registered direct offering

Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) announced it has entered into a securities purchase agreement for a registered direct offering expected to generate approximately $2.0 million in gross proceeds.

The offering consists of up to 1,133,332 Class A ordinary shares and pre-funded warrants to purchase up to 200,000 Class A ordinary shares, priced at $1.50 per share and warrant. The transaction is expected to close on or about June 15, 2026, subject to customary closing conditions.

D. Boral Capital LLC is serving as the sole placement agent for the offering. The company plans to use net proceeds for general corporate and working capital purposes.

The securities are being offered under an effective shelf registration statement on Form F-3 that was declared effective by the Securities and Exchange Commission on June 8, 2026.

Park Ha Biological Technology, established in 2016, develops skincare products and operates retail locations under the "Park Ha" brand. As of October 31, 2025, the company operated five directly owned stores and had 22 franchisees in China. The Cayman Islands-incorporated company focuses on skincare product sales and franchise operations.

You May Also Be Interested In

• Columbus Circle Capital Corp. III closes $230M IPO on Nasdaq
• Basel Medical Group regains Nasdaq minimum bid price compliance
• Data I/O signs non-binding LOI to buy embedded security assets from IAR